Decline in Elan shares continues

MOST European markets ended the day’s trading in positive territory yesterday, while shares in Dublin fell for a third consecutive day.

The ISEQ ended the week 11.11 points lower at 6264.84.

Elan’s decline continued, leaving the stock 1.10 lighter at €4.47. Over 1.8 million shares were traded following news that infection has been confirmed in a second patient receiving the multiple sclerosis drug, Tysabri.